PD-L1 is one of the key immune-checkpoints that can play an important role in immune escape of cancer cells; and it has been reported that PD1 expressed by tumor-infiltrating immune cells is associated with poor outcome of renal cancer patients [37]. Here, CD274 is linked to cancer.